GOLDMAN SACHS & CO. LLC 13D/13G Filings for ProQR Therapeutics N.V. (PRQR)

GOLDMAN SACHS & CO. LLC 13D and 13G filings for ProQR Therapeutics N.V.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-12
1:02 pm
Purchase
2020-12-3113GProQR Therapeutics N.V.
PRQR
GOLDMAN SACHS & CO. LLC3,297,270
6.600%
3,297,270increase
(New Position)
Filing